rivaroxaban polpharma 2,5 mg comprimidos recubiertos con pelicula efg, 56 comprimido
rivaroxaban polpharma 20 mg comprimidos recubiertos con pelicula efg, 28 comprimidos
rivaroxaban polpharma 20 mg comprimidos recubiertos con pelicula efg, 100 comprimido
sitagliptina/metformina polpharma 50 mg/850 mg comprimidos recubiertos con pelicula
ranivisio
midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmológicos - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).
corazem 120 mg capsulas de liberacion prolongada
laboratorios farma, s.a. - diltiazem - c - 120 mg
nifelan 30 mg tabletas recubiertas de liberacion prolongada
laboratorios farma, s.a. - italia - tableta recubierta de liberaci - 30 mg
gemfibrozilo 600 mg tableta recubierta
inversiones indaura e.i.r.l. - tableta recubierta - por tableta - gemfibrozilo
aciclovir 5% unguento
inversiones indaura e.i.r.l. - unguento - por gramo 100.00 g - aciclovir
hidroxizina 25mg tableta
inversiones indaura e.i.r.l. - tableta - por tableta - hidroxizina